Can Gene Therapy Cure Blindness?
Since the approval of the first gene therapy for blindness, there has been a wave…
March 10, 2021 - 7 minutes
NightstaRx
Biogen Acquires UK Biotech Developing Gene Therapy for Blindness
The big US biotech Biogen has agreed to acquire Nightstar Therapeutics for €773M ($877M), including…
March 4, 2019 - 2 minutes
Gene Therapy Improves Eyesight of Patients With Inherited Blindness
UK startup Nightstar Therapeutics has reported good safety and early signs of visual improvements in…
September 24, 2018 - 2 minutes
Oxford Spin-out Moves Gene Therapy For Blindness Into Phase III Trial
Nightstar Therapeutics will begin the first Phase III trial for a gene therapy targeting choroideremia,…
March 6, 2018 - 2 minutes
Happy 2018, Here Are the Top 9 European Biotech Companies To Watch
As the 2017 reports roll in, we're already turning our gaze to 2018. These are…
January 9, 2018 - 5 minutes
Oxford Spinout goes for $75M IPO on Nasdaq to Fund Gene Therapy Programs
Nightstar has gone public on the American market with the aim of raising $75M for its…
September 28, 2017 - 2 minutes
€40M in Series C for a British Biotech Treating Blindness with Gene Therapy
NightstaRx has raised €39.5M that will go towards three clinical programs testing gene therapies for…
June 30, 2017 - 3 minutes
Oxford’s Nightstar Gene Therapy for Blindness in Men Shines with $35M Fundraiser
Choroideremia is a rare X-linked recessive retinal disease which eventually leads to blindness. A series…
November 11, 2015 - 3 minutes
